Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-062132·Caris Life Sciences, Inc.
Schedule 13G ownership disclosure
Caris Life Sciences Inc
Common Stock, par value $0.001 per share · CUSIP: 142152107
Event date: 2025-06-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Riverview Group LLC
Shares: 2,985,503.00 · Class: 1.1%
- Millennium Management LLC
Shares: 3,583,100.00 · Class: 1.3%
- Millennium Group Management LLC
Shares: 3,583,100.00 · Class: 1.3%
- Israel A. Englander
Shares: 3,583,100.00 · Class: 1.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-062132
- Form type
- SCHEDULE 13G
- Filer
- Caris Life Sciences, Inc.
- CIK
- CIK 2019410
- Filed
- Jun 24, 2025
- Reporting period
- Jun 17, 2025
- Description
- Schedule 13G beneficial ownership